
UnitedHealth Group (UNH) shares have recently underperformed, returning -11.4% over the past month compared to the S&P 500's +1.3% gain, though its industry also saw a decline. While the largest U.S. health insurer faces projected significant year-over-year EPS declines for the current quarter and fiscal year, consensus estimates have seen modest upward revisions over the last 30 days. The company reported strong revenue growth of +12.2% last quarter and forecasts continued double-digit revenue expansion for the current fiscal year. UNH currently holds a Zacks Rank #3 (Hold), suggesting it may perform in line with the broader market, and its Zacks Value Style Score of 'A' indicates it trades at a discount to peers.
UnitedHealth Group (UNH) has experienced significant underperformance recently, with shares returning -11.4% over the past month, lagging both the S&P 500's +1.3% and its industry's -10.3% decline. This market reaction contrasts with the company's robust revenue growth, which saw a +12.2% year-over-year increase in the last reported quarter and is projected to continue with +12.7% for the current quarter and +11.9% for the current fiscal year. The company faces substantial projected year-over-year EPS declines, with the current quarter estimated at $2.08 (-69.5% YoY) and the current fiscal year at $16.31 (-41% YoY). However, consensus estimates for all periods have seen modest upward revisions over the last 30 days, with the next fiscal year's EPS projected to rebound to $17.71, an +8.6% increase. UNH currently holds a Zacks Rank #3 (Hold), suggesting its near-term price performance may align with the broader market. Furthermore, its Zacks Value Style Score of 'A' indicates the stock is trading at a discount relative to its peers, potentially offering a compelling entry point for value-oriented investors. The company's mixed surprise history, with two EPS beats and one revenue beat over the last four quarters, suggests some volatility in meeting expectations.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
mixed
Sentiment Score
-0.10
Ticker Sentiment